Brief Title
Effectiveness of the uPatient Platform in Prophylactic Treatment in Hemophilia
Official Title
Effectiveness of the uPatient Platform in the Fulfillment of the Prophylactic Treatment in Patients With Hemophilia
Brief Summary
Research project whose main objective is to evaluate the use of a technology platform (uPatient) to register the prophylactic treatment of patients with hemophilia treated in different Hematology and Hemotherapy services of several hospitals in Spain.
Detailed Description
The data obtained in this project will identify the level of compliance to the pharmacological treatment of patients with hemophilia prophylaxis. They will use different psychosocial questionnaires based on scientific evidence and the reliability of these, as well as its specific design for patients with hemophilia. Clinical data were also obtained regarding the joint of patients participating in the study state.
Study Type
Observational
Primary Outcome
Registration of the uPatient platform
Condition
Haemophilia
Intervention
Patients with haemophilia
Study Arms / Comparison Groups
Patients with haemophilia
Description: Using the platform Upatient, patients with hemophilia will register for one year, the prophylactic treatment who receive at home. Likewise, they indicate a replacement therapy as a result of joint bleeds. At baseline, a month, 6 months and at the end of the study, patients shall complete two questionnaires. The same way in the initial evaluation and end of the study, the clinical joint status will be evaluated with HJHS scale .
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Other
Estimated Enrollment
40
Start Date
October 2015
Completion Date
November 2016
Primary Completion Date
November 2016
Eligibility Criteria
Inclusion Criteria: - Patients diagnosed with hemophilia A or B - Patients over 13 years old - Patients on prophylactic treatment. Exclusion Criteria: - Patients who do not sign the informed consent document - Patients who do not make domiciliary self-treatment - Patients who do not have good adhesion to prophylactic treatment
Gender
Male
Ages
13 Years - 50 Years
Accepts Healthy Volunteers
No
Contacts
Rubén Cuesta-Barriuso, PhD, ,
Administrative Informations
NCT ID
NCT02581735
Organization ID
uPatient
Responsible Party
Sponsor
Study Sponsor
Real Fundación Victoria Eugenia
Collaborators
Universidad de Murcia
Study Sponsor
Rubén Cuesta-Barriuso, PhD, Principal Investigator, Real Fundación Victoria Eugenia
Verification Date
June 2016